Objectives: This is the second of a pair of studies designed to evaluate the efficacy and
safety of onabotulinumtoxinA (BOTOX®) for prophylaxis of headaches in adults with chronic …

Objectives: This is the first of a pair of studies designed to assess efficacy, safety and
tolerability of onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with chronic …

Objective.—To evaluate safety and efficacy of onabotulinumtoxinA (BOTOX®) as headache
prophylaxis in adults with chronic migraine. Background.—Chronic migraine is a prevalent …

(Headache 2010; 50: 921‐936) Objective.—To assess the efficacy, safety, and tolerability of
onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with chronic migraine …

Objective Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase
III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program …

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine
(CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional …

Background OnabotulinumtoxinA is approved for the prevention of headache in those with
chronic migraine (CM); however, more clinical data on the risk-benefit profile for treatment …

Background Chronic migraine affects 2% of the population. It results in substantial disability
and reduced quality of life. Medications used for prophylaxis in episodic migraine may also …

Background and purpose OnabotulinumtoxinA is a treatment specifically approved for the
prophylaxis of chronic migraine in adults. The aim of this study was to assess the …

Background This meta-analysis evaluated the real-world effectiveness of
onabotulinumtoxinA (BOTOX®), the first preventive treatment FDA-approved specifically for …